Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Focused ultrasound earns praise as a surgical alternative for Parkinson’s patients

“The key for the ultimate adoption of this new procedure will be further refinements of the technology to ensure reliability and safety," University of Virginia Health researchers explained.

Thumbnail

Pfizer agrees to new PET license, supply deal with cancer imaging firm ImaginAb

As part of the contract, Los Angeles-based ImaginAb will provide Pfizer will its 89Zr CD8 immuno-PET agent, which is used to image CD8 T cells in cancer patients.

Medical imaging-based ‘virtual biopsies’ move closer to replacing traditional tissue techniques

The new approach relies on radiomic CT data combined with ultrasound imaging to create a visual guide for doctors, researchers explained in European Radiology.

Thumbnail

Hitachi inks five-year deal with Olympus to jointly develop endoscopic ultrasound systems

Officials said the pact will remain in place after Hitachi completes the sale of its imaging products to Fujifilm. 

Thumbnail

NorthStar’s recent FDA approval enables a fourfold increase in Mo-99 production

This marks the first and only commercial-scale application of concentrated molybdenum-98 technology, the Beloit, Wisconsin-based firm said recently.

Thumbnail

Interventional radiology community calls on WHO to enhance access to IR services across the globe

Specifically, the open letter urges the World Health Organization to address the IR care gap between low- and high-income countries.

Thumbnail

New copper PET tracer one-two punch identifies deadly tumors and boosts survival

“This offers the potential to provide diagnostic imaging using copper-64 to plan individualized treatments with copper-67 agents for a wide range of cancer patients," Australian researchers explained in the Journal of Nuclear Medicine.

COVID-19 patients with neurological problems requiring brain imaging face increased risk of death

Those who underwent neuroimaging and were diagnosed with stroke were also twice as likely to die compared to age-matched controls, according to new research published in Neurology.